#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 5

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Factor VIII deficiency

Not recruiting

Registered drugNo placebo

Study on Long-Term Effects of Efanesoctocog Alfa in Preventing Joint Bleeds in Patients with Hemophilia A

Registered drugNo placebo

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Efanesoctocog Alfa

Contact Research Centre

Hereditary angioedema

Not recruiting

Registered drug

Study of Deucrictibant Extended-Release Tablets for Prevention of Hereditary Angioedema Attacks in Adults and Adolescents

Registered drug

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Deucrictibant

Contact Research Centre

Multiple system atrophy

Not recruiting

Investigational

Study of Amlenetug for Patients with Multiple System Atrophy

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:AMLENETUG

Contact Research Centre

Follicular lymphoma

Not recruiting

Registered drugNo placebo

Study Comparing Shortened vs Standard Chemotherapy with Rituximab for Initial Treatment of High Tumor Burden Follicular Lymphoma in Newly Diagnosed Patients

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Bendamustine

Contact Research Centre

Acute lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study of Inotuzumab Ozogamicin and drug combination in adult patients with B-cell Acute Lymphoblastic Leukemia who have minimal residual disease before stem cell transplantation

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Parkinson's disease

Not recruiting

Investigational

Study on the Effects and Safety of Prasinezumab for Patients with Early Parkinson's Disease

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Prasinezumab

Contact Research Centre

Bladder cancer

Not recruiting

Registered drug

Study of Visugromab and Nivolumab for Patients with Muscle-Invasive Bladder Cancer Who Cannot or Refuse Cisplatin Chemotherapy

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study of venetoclax with fludarabine, cytarabine and idarubicin combination therapy in newly diagnosed patients with intermediate or high-risk Acute Myeloid Leukemia

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cytarabine

Contact Research Centre

Progressive supranuclear palsy

Not recruiting

Investigational

Study of FNP-223 tablets to slow disease progression in patients with Progressive Supranuclear Palsy (PSP)

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:(S)-N-(5-(4-(1-(Benzo[D][1,3]Dioxol-5-Yl)Ethyl)Piperazin-1-Yl)-1,3,4-Thiadiazol-2-Yl)Acetamide, Hydrochloride Salt

Contact Research Centre

Systemic lupus erythematosus+3

Not recruiting

Registered drugNo placebo

Study on the Effects of Ianalumab in Adults with Rheumatoid Arthritis, Systemic Lupus Erythematosus, or Sjögren’s Disease

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Emtricitabine

Contact Research Centre

Acute lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study on Ponatinib and Chemotherapy for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cytarabine

Contact Research Centre

Metastatic renal cell carcinoma

Not recruiting

Registered drugNo placebo

Study on Pembrolizumab for Patients with Resectable Metastases from Kidney Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.